Malignant Vulvar Neoplasm — Trials

Malignant Vulvar Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

184 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 54
Recruiting: 32
Ph III recruiting: 1
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 21.3%
Trials / 1,000 deaths: 36.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01079832	Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies	completed	Phase 2	50	Case Comprehensive Cancer CenterOTHER	1	Nov 28, 2013	clinicaltrials
NCT00014599	Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva	completed	Phase 2	31	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	6	Sep 24, 2012